Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Autism as a brain energy disorder: How impairments in brain glucose metabolism give rise to autism symptoms. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2013 · External reference
Risk of autoimmune disease in research-identified cases of autism spectrum disorder: a longitudinal, population-based birth cohort study
10.1097/dbp.0000000000001232 · 2024 · External reference
Association between autism spectrum disorder and inflammatory bowel disease: a systematic review and meta-analysis
10.1002/aur.2656 · 2022 · External reference
Autism spectrum disorder and epilepsy
10.1016/j.ncl.2022.03.011 · 2022 · External reference
Autism spectrum disorder and schizophrenia: an updated conceptual review
10.1002/aur.2659 · 2022 · External reference
Autism and depression are connected: a report of two complimentary network studies
10.1177/1362361319872373 · 2020 · External reference
The co-occurrence of autistic spectrum disorder and schizophrenia: a nationwide population-based study
10.1016/j.jpsychires.2021.04.012 · 2021 · External reference
Occurrence of psychosis and bipolar disorder in adults with autism: a systematic review and meta-analysis
10.1016/j.neubiorev.2022.104543 · 2022 · External reference
Prevalence of dementia among US adults with autism spectrum disorder
10.1001/jamanetworkopen.2024.53691 · 2025 · External reference
Risk of Parkinson disease in individuals with autism spectrum disorder
10.1001/jamaneurol.2025.1284 · 2025 · External reference
Neurodevelopmental hypothesis about the etiology of autism spectrum disorders
10.3389/fnhum.2017.00354 · 2017 · External reference
Autism spectrum disorder symptoms are associated with connectivity between large-scale neural networks and brain regions involved in social processing
10.1007/s10803-020-04383-w · 2020 · External reference
Energy metabolism in childhood neurodevelopmental disorders
2021 · External reference
Astrocyte-derived ATP: a new etiological factor for autism spectrum disorder
10.1007/s12264-021-00788-4 · 2022 · External reference
Metabolic dynamics in astrocytes and microglia during post-natal development and their implications for autism spectrum disorders
10.3389/fncel.2024.1354259 · 2024 · External reference
Mini-review: brain energy metabolism and its role in animal models of depression, bipolar disorder, schizophrenia and autism
10.1016/j.neulet.2021.136003 · 2021 · External reference
Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders
10.1016/j.neubiorev.2022.104892 · 2022 · External reference
Involvement of brain metabolism in neurodevelopmental disorders
10.1016/bs.irn.2023.08.004 · 2023 · External reference
Brain power
10.1073/pnas.2107022118 · 2021 · External reference
The brain selectively allocates energy to functional brain networks under cognitive control
10.1038/s41598-024-83696-7 · 2024 · External reference
Attention and capacity limits in perception: a cellular metabolism account
10.1523/jneurosci.2368-19.2020 · 2020 · External reference
The control costs of human brain dynamics
10.1162/netn_a_00425 · 2025 · External reference
Cognitive cost as dynamic allocation of energetic resources
10.3389/fnins.2015.00289 · 2015 · External reference
An energy costly architecture of neuromodulators for human brain evolution and cognition
10.1126/sciadv.adi7632 · 2023 · External reference
Correspondence between cerebral glucose metabolism and BOLD reveals relative power and cost in human brain
10.1038/s41467-019-08546-x · 2019 · External reference
Control of brain energy supply by astrocytes
10.1016/j.conb.2017.09.012 · 2017 · External reference
Brain energy homeostasis: the evolution of the astrocyte-neuron lactate shuttle hypothesis
10.4196/kjpp.24.388 · 2025 · External reference
Glucose sparing by glycogenolysis (GSG) determines the relationship between brain metabolism and neurotransmission
10.1177/0271678x211064399 · 2022 · External reference
Astrocytes drive divergent metabolic gene expression in humans and chimpanzees
10.1093/gbe/evad239 · 2024 · External reference
Molecular signature of primate astrocytes reveals pathways and regulatory changes contributing to human brain evolution
10.1016/j.stem.2024.12.011 · 2025 · External reference
Comparative analysis of astrocytes in the prefrontal cortex of primates: insights into the evolution of human brain energetics
10.1002/cne.25387 · 2022 · External reference
Astrocytic glycolysis attenuates mitochondrial efficiency to preserve cognition
2025 · External reference
The role of astrocyte-mediated plasticity in neural circuit development and function
10.1186/s13064-020-00151-9 · 2021 · External reference
Brain stars take the lead during critical periods of early postnatal brain development: relevance of astrocytes in health and mental disorders
10.1038/s41380-024-02534-4 · 2024 · External reference
From synapses to circuits, astrocytes regulate behavior
2022 · External reference
Developmental neural activity requires neuron–astrocyte interactions
10.1002/dneu.22870 · 2022 · External reference
Adenosine and astrocytes determine the developmental dynamics of spike timing-dependent plasticity in the somatosensory cortex
10.1523/jneurosci.0115-22.2022 · 2022 · External reference
Energetic substrate availability regulates synchronous activity in an excitatory neural network
10.1371/journal.pone.0220937 · 2019 · External reference
The effects of early-life iron deficiency on brain energy metabolism
10.1177/2633105520935104 · 2020 · External reference
Aberrant “deep connectivity” in autism: a cortico–subcortical functional connectivity magnetic resonance imaging study
10.1002/aur.2058 · 2019 · External reference
Abnormal resting-state brain network dynamics in toddlers with autism spectrum disorder
10.1007/s00787-025-02651-7 · 2025 · External reference
Aberrant cerebellar–cerebral functional connectivity in children and adolescents with autism spectrum disorder
10.3389/fnhum.2018.00454 · 2018 · External reference
Astrocyte metabolism and signaling pathways in the CNS
2023 · External reference
Aspects of astrocyte energy metabolism, amino acid neurotransmitter homoeostasis and metabolic compartmentation
10.1042/an20120007 · 2012 · External reference
Brain energy constraints and vulnerability
2025 · External reference
Functional connectivity between the amygdala and prefrontal cortex underlies processing of emotion ambiguity
10.1038/s41398-023-02625-w · 2023 · External reference
The language, tone and prosody of emotions: neural substrates and dynamics of spoken-word emotion perception
10.3389/fnins.2016.00506 · 2016 · External reference
Social bandwidth: when and why are social interactions energy intensive?
10.1177/02654075231154937 · 2023 · External reference
Energetic cost of brain functional connectivity
10.1073/pnas.1303346110 · 2013 · External reference
Cerebral energy metabolism and the Brain's functional network architecture: an integrative review
10.1038/jcbfm.2013.94 · 2013 · External reference
Synaptic signaling modeled by functional connectivity predicts metabolic demands of the human brain
10.1016/j.neuroimage.2024.120658 · 2024 · External reference
A study of the correlation between VEP and clinical severity in children with autism spectrum disorder
2018 · External reference
Delayed M50/M100 evoked response component latency in minimally verbal/nonverbal children who have autism spectrum disorder
10.1186/s13229-019-0283-3 · 2019 · External reference
Abnormal auditory mismatch fields are associated with communication impairment in both verbal and minimally verbal/nonverbal children who have autism spectrum disorder
10.1002/aur.2136 · 2019 · External reference
Audition-specific temporal processing deficits associated with language function in children with autism spectrum disorder
10.1002/aur.1820 · 2017 · External reference
Atypical audio-visual neural synchrony and speech processing in early autism
10.1186/s11689-025-09593-w · 2025 · External reference
The impact of atypical sensory processing on social impairments in autism spectrum disorder
10.1016/j.dcn.2017.04.010 · 2018 · External reference
Neurophysiological measures of auditory sensory processing are associated with adaptive behavior in children with autism spectrum disorder
10.1186/s11689-023-09480-2 · 2023 · External reference
Multisensory temporal integration in autism spectrum disorders
10.1523/jneurosci.3615-13.2014 · 2014 · External reference
Reconfiguration of functional brain networks and metabolic cost converge during task performance
10.7554/elife.52443 · 2020 · External reference
Evoked and intrinsic brain network dynamics in children with autism spectrum disorder
10.1016/j.nicl.2020.102396 · 2020 · External reference
Resting-state functional connectivity in autism spectrum disorders: a review
10.3389/fpsyt.2016.00205 · 2017 · External reference
Altered structural balance of resting-state networks in autism
10.1038/s41598-020-80330-0 · 2021 · External reference
Contributions of glycogen to astrocytic energetics during brain activation
10.1007/s11011-014-9493-8 · 2015 · External reference
Effect of afferent brachial stimulation and photic stimulation on glycogen concentration in cortical brain tissue
10.1016/0197-0186(90)90078-8 · 1990 · External reference
Acute hypoglycemia decreases central retinal function in the human eye
10.1016/j.visres.2011.05.003 · 2011 · External reference
Effects of acute hypoglycaemia on auditory information processing in adults with type I diabetes
10.1007/s00125-002-0950-2 · 2003 · External reference
A quantitative meta-analysis of face recognition deficits in autism: 40 years of research
10.1037/bul0000310 · 2021 · External reference
Impaired memory for faces and social scenes in autism: clinical implications of memory dysfunction
10.1016/j.acn.2002.08.001 · 2005 · External reference
Consistent effects of hypoglycemia on cognitive function in people with or without diabetes
10.2337/dc21-2502 · 2022 · External reference
Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetes
10.2337/diacare.26.2.390 · 2003 · External reference
Glucose regulation and face recognition deficits in older adults: the role of attention
10.1080/13825585.2017.1365813 · 2018 · External reference
Brain activation during working memory is altered in patients with type 1 diabetes during hypoglycemia
10.2337/db11-0506 · 2011 · External reference
Facial expression recognition in patients with type 2 diabetes mellitus
10.21037/atm.2019.10.68 · 2019 · External reference
Glucose enhancement of face recognition is unaffected by alterations of face features
10.1016/s1074-7427(03)00058-3 · 2003 · External reference
Language and verbal memory in individuals with a history of autism spectrum disorders who have achieved optimal outcomes
10.1007/s10803-013-1921-9 · 2014 · External reference
Working memory, language skills, and autism symptomatology
10.3390/bs2040207 · 2012 · External reference
A preliminary examination of the impact of working memory training on syntax and processing speed in children with ASD
10.1007/s10803-021-05295-z · 2022 · External reference
Working memory training in autism: near and far transfer
2023 · External reference
Effects of acute hypoglycemia on working memory and language processing in adults with and without type 1 diabetes
10.2337/dc14-1657 · 2015 · External reference
Linear effects of glucose levels on voice fundamental frequency in type 2 diabetes and individuals with normoglycemia
10.1038/s41598-024-69620-z · 2024 · External reference
GLUT1DS focus on dysarthria
10.1016/j.ejpn.2024.05.010 · 2024 · External reference
Executive function in autism spectrum disorder: history, theoretical models, empirical findings, and potential as an endophenotype
10.3389/fpsyt.2019.00753 · 2019 · External reference
Childhood executive function predicts later autistic features and adaptive behavior in young autistic people: a 12-year prospective study
10.1007/s10802-018-0493-8 · 2019 · External reference
Influence of autism traits and executive functioning on quality of life in children with an autism spectrum disorder
10.1007/s10803-015-2438-1 · 2015 · External reference
Self-regulation and quality of life in high-functioning young adults with autism
10.1177/1362361316655525 · 2017 · External reference
Executive dysfunction, violence and aggression
10.1016/j.avb.2020.101380 · 2020 · External reference
The relationship between emotion regulation, executive functioning, and aggressive behaviors
10.1177/0886260515592619 · 2017 · External reference
Executive functions in preschool children with aggressive behavior: impairments in inhibitory control
10.1007/s10802-008-9235-7 · 2008 · External reference
Emotion dysregulation and depressive symptoms mediate the association between inhibitory control difficulties and aggressive behaviour in children with ADHD
10.3389/fpsyt.2024.1329401 · 2024 · External reference
Executive functions and emotion regulation in children with autism spectrum disorders
10.1080/08856257.2023.2215010 · 2024 · External reference
Adaptive skills and executive function in autism spectrum disorders
10.1076/chin.8.4.241.13504 · 2002 · External reference
Communicative abilities in autism: evidence for attentional deficits
10.1006/brln.2000.2429 · 2001 · External reference
The role of executive functions in preschool children with autism spectrum disorder: a short narrative review
10.1016/j.ridd.2024.104905 · 2025 · External reference
A meta-analysis of cognitive flexibility in autism spectrum disorder
10.1016/j.neubiorev.2023.105511 · 2024 · External reference
Mental work requires physical energy: self-control is neither exception nor exceptional
10.3389/fpsyg.2018.01005 · 2018 · External reference
The allostatic triage model of psychopathology (ATP Model): how reallocation of brain energetic resources under stress elicits psychiatric symptoms
10.1016/j.neubiorev.2025.106419 · 2025 · External reference
Improved self-control associated with using relatively large amounts of glucose: learning self-control is metabolically expensive
10.4236/psych.2012.311148 · 2012 · External reference
Fuel for thought? A systematic review of neuroimaging studies into glucose enhancement of cognitive performance
10.1007/s11065-020-09431-x · 2020 · External reference
Near-infrared imaging of the effects of glucose ingestion and regulation on prefrontal activation during dual-task execution in healthy fasting older adults
10.1016/j.bbr.2012.03.039 · 2012 · External reference
Impulsiveness, postprandial blood glucose, and glucoregulation affect measures of behavioral flexibility
10.1016/j.nutres.2017.10.011 · 2017 · External reference
Verbal fluency in metabolic syndrome
10.3390/brainsci12020255 · 2022 · External reference
Hypoglycemia and aggression: a review
10.3109/00207458808990722 · 1988 · External reference
Sweetened blood cools hot tempers: physiological self-control and aggression
10.1002/ab.20366 · 2011 · External reference
Hangry in the field: an experience sampling study on the impact of hunger on anger, irritability, and affect
10.1371/journal.pone.0269629 · 2022 · External reference
Hypoglycaemia induces emotional disruption
10.1016/0738-3991(96)00940-8 · 1996 · External reference
Homeostasis to allostasis: prefrontal astrocyte roles in cognitive flexibility and stress biology
10.1007/978-3-031-64839-7_6 · 2024 · External reference
Astrocytes as key regulators of brain energy metabolism: new therapeutic perspectives
10.3389/fphys.2021.825816 · 2022 · External reference
Overactivation of prefrontal astrocytes impairs cognition through the metabolic pathway of central kynurenines
2024 · External reference
Astrocytes in neuropathologies affecting the frontal cortex
10.3389/fncel.2019.00044 · 2019 · External reference
Unlocking the energy dynamics of executive functioning: linking executive functioning to brain glycogen
10.1111/j.1745-6924.2008.00077.x · 2008 · External reference
Cognitive profile of patients with glycogen storage disease type III: a clinical description of seven cases
10.1007/s10545-014-9789-1 · 2015 · External reference
Decreased number and increased activation state of astrocytes in gray and white matter of the prefrontal cortex in autism
10.1093/cercor/bhab523 · 2022 · External reference
Neural substrates underlying effortful control deficit in autism spectrum disorder: a meta-analysis of fMRI studies
10.1038/s41598-022-25051-2 · 2022 · External reference
Glucose metabolism echoes long-range temporal correlations in the human brain
2025 · External reference
Quantitative positron emission tomography reveals regional differences in aerobic glycolysis within the human brain
10.1177/0271678x18767005 · 2019 · External reference
Five energy metabolism pathways show distinct regional distributions and lifespan trajectories in the human brain
10.1371/journal.pbio.3003619 · 2026 · External reference
Brain glucodynamic variability is an essential feature of the metabolism–cognition relationship
10.1073/pnas.2510850123 · 2026 · External reference
Disentangling the switching behavior in functional connectivity dynamics in autism spectrum disorder: insights from developmental cohort analysis and molecular-cellular associations
2025 · External reference
Cross-sectional investigation of insulin resistance in youths with autism spectrum disorder. Any role for reduced brain glucose metabolism?
10.1038/s41398-021-01345-3 · 2021 · External reference
Cellular bioenergetic and metabolic changes in patients with autism spectrum disorder
10.2174/1568026621666210521142131 · 2021 · External reference
Hypometabolism in autism spectrum disorder: insights from brain and blood transcriptomics
10.1007/s12035-025-04941-2 · 2025 · External reference
Metabolomic biomarkers in autism: identification of complex dysregulations of cellular bioenergetics
10.3389/fpsyt.2023.1249578 · 2023 · External reference
Metabolomic signatures of autism spectrum disorder
10.3390/jpm12101727 · 2022 · External reference
Activities of key glycolytic enzymes in the plasma of Saudi autistic patients
10.2147/oajct.s8074 · 2010 · External reference
Metabolic biomarkers related to energy metabolism in Saudi autistic children
10.1016/j.clinbiochem.2009.04.006 · 2009 · External reference
1H-NMR-Based metabolomics in autism spectrum disorder and pediatric acute-onset neuropsychiatric syndrome
10.3390/jcm11216493 · 2022 · External reference
Disrupted fetal carbohydrate metabolism in children with autism spectrum disorder
10.1186/s11689-025-09601-z · 2025 · External reference
Metabolomic analysis of maternal mid-gestation plasma and cord blood in autism spectrum disorders
10.1038/s41380-023-02051-w · 2023 · External reference
An impaired glycolysis induces ATP deficiency and reduced cell respiration in stem cells of patients with autism spectrum disorders
10.1038/s41598-025-22327-1 · 2025 · External reference
Proteomic phenotype of cerebral organoids derived from autism spectrum disorder patients reveal disrupted energy metabolism, cellular components, and biological processes
10.1038/s41380-022-01627-2 · 2022 · External reference
Changes of expressions of aerobic glycolytic enzymes in prefrontal cortex of patients with autism
2015 · External reference
Metabolome signature of autism in the human prefrontal cortex
10.1038/s42003-019-0485-4 · 2019 · External reference
Regional cerebral glucose metabolism and its association with phenotype and cognitive functioning in patients with autism
10.4103/0253-7176.207344 · 2017 · External reference
Brain laterality evaluated by F-18 fluorodeoxyglucose positron emission computed tomography in autism spectrum disorders
10.3389/fnmol.2022.901016 · 2022 · External reference
The baseline pattern and age-related developmental metabolic changes in the brain of children with autism as measured on positron emission tomography/computed tomography scan
10.4103/wjnm.wjnm_29_17 · 2018 · External reference
Cerebral glucose metabolism: the potential missing link in autism research-a literature review and meta-analytic synthesis
10.1007/s00702-025-03093-w · 2026 · External reference
Parsing the heterogeneity of brain metabolic disturbances in autism spectrum disorder
10.1016/j.biopsych.2019.06.010 · 2020 · External reference
Elevated GFAP protein in anterior cingulate cortical white matter in males with autism spectrum disorder
10.1002/aur.1480 · 2015 · External reference
Chronic inhibition of astrocytic aquaporin-4 induces autistic-like behavior in control rat offspring similar to maternal exposure to valproic acid
10.1016/j.physbeh.2023.114286 · 2023 · External reference
Expression of astrocytic markers aquaporin 4 and connexin 43 is altered in brains of subjects with autism
10.1002/syn.20519 · 2008 · External reference
Astrocytes derived from ASD individuals alter behavior and destabilize neuronal activity through aberrant Ca2+ signaling
10.1038/s41380-022-01486-x · 2022 · External reference
Modeling the interplay between neurons and astrocytes in autism using human induced pluripotent stem cells
10.1016/j.biopsych.2017.09.021 · 2018 · External reference
A functional signature in the developing cerebellum: evidence from a preclinical model of autism
10.3389/fcell.2021.727079 · 2021 · External reference
Impaired calcium signaling in astrocytes modulates autism spectrum disorder-like behaviors in mice
10.1038/s41467-021-23843-0 · 2021 · External reference
Auts2 regulated autism-like behavior, glucose metabolism and oxidative stress in mice
10.1016/j.expneurol.2022.114298 · 2023 · External reference
Axin2 coupled excessive wnt-glycolysis signaling mediates social defect in autism spectrum disorders
10.15252/emmm.202217101 · 2023 · External reference
Mitochondrial dysregulation as a central mechanism in autism spectrum disorder pathogenesis
10.1016/j.jneuroim.2025.578851 · 2026 · External reference
Therapeutic efficacy of a synthetic brain-targeted H2S donor cross-linked nanomicelle in autism spectrum disorder rats through aerobic glycolysis
10.1021/acsami.4c11663 · 2025 · External reference
Mesenchymal stem cell-derived extracellular vesicles alleviate autism by regulating microglial glucose metabolism reprogramming and neuroinflammation through PD-1/PD-L1 interaction
10.1186/s12951-025-03250-z · 2025 · External reference
RVG engineered extracellular vesicles-transmitted miR-137 improves autism by modulating glucose metabolism and neuroinflammation
10.1038/s41380-025-02988-0 · 2025 · External reference
The role of astrocyte metabolic reprogramming in ischemic stroke
10.3892/ijmm.2025.5490 · 2025 · External reference
Activation of Wnt signaling in cortical neurons enhances glucose utilization through glycolysis
10.1074/jbc.m116.735373 · 2016 · External reference
GLUT1-DS brain organoids exhibit increased sensitivity to metabolic and pharmacological induction of epileptiform activity
10.3390/ph19010105 · 2026 · External reference
Deficiencia del transportador de glucosa tipo 1: Aspectos clínicos, diagnóstico y terapéutica [Glucose transporter type 1 deficiency syndrome: clinical aspects, diagnosis, and treatment]
2022 · External reference
GLUT1 deficiency syndrome: a case report with a novel SLC2A1 mutation
10.2298/vsp170406120i · 2019 · External reference
Transgenic expression of the human glucose Transporter1 (GLUT1) gene locus reduces disease burden in Glut1 deficiency syndrome model mice
10.1016/j.nbd.2025.107047 · 2025 · External reference
Behavioral features in Phelan–McDermid syndrome: characteristics and genetic and metabolic contributions in a cohort of 56 individuals
10.3390/genes17020202 · 2026 · External reference
Association between maternal diabetes and neurodevelopmental outcomes in children: a systematic review and meta-analysis of 202 observational studies comprising 56·1 million pregnancies
10.1016/s2213-8587(25)00036-1 · 2025 · External reference
Maternal diabetes during pregnancy and offspring's risk of autism spectrum disorder: a systematic review and meta-analysis
10.1016/j.jpsychires.2025.01.003 · 2025 · External reference
Autism spectrum disorders: let's talk about glucose?
10.1038/s41398-019-0370-4 · 2019 · External reference
Association between type 1 diabetes and neurodevelopmental disorders in children and adolescents: a systematic review and meta-analysis
10.3389/fpsyt.2022.982696 · 2022 · External reference
Poor glycaemic control is associated with increased risk of neurodevelopmental disorders in childhood-onset type 1 diabetes: a population-based cohort study
10.1007/s00125-020-05372-5 · 2021 · External reference
Executive function in adults with type 2 diabetes: a meta-analytic review
10.1097/psy.0000000000000103 · 2015 · External reference
Management of adults with diabetes and cognitive problems
10.2337/ds16-0035 · 2016 · External reference
Executive function and diabetes: a clinical neuropsychology perspective
10.3389/fpsyg.2020.02112 · 2020 · External reference
Adolescents with type 1 diabetes mellitus experience psychosensorial symptoms during hypoglycaemia
10.1111/dme.12533 · 2014 · External reference
Emotional changes during experimentally induced hypoglycaemia in type 1 diabetes
10.1016/s0301-0511(03)00027-9 · 2003 · External reference
Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes
10.2337/diacare.28.1.71 · 2005 · External reference
Contribution of tactile dysfunction to manual motor dysfunction in type II diabetes
10.1002/mus.25137 · 2016 · External reference
Detecting subtle fingertip sensory and motor dysfunction in adults with type II diabetes
10.1007/s00221-014-3844-x · 2014 · External reference
Comparisons of children with and without type I diabetes on hand and visual motor integration skills and on participation in daily activities
10.1177/00315125221101008 · 2022 · External reference
The effect of poor glycemic control on cognitive function in children and adolescents with type 1 diabetes mellitus: a single-center cross-sectional study (2019–2020)
10.15537/smj.2023.44.20230327 · 2023 · External reference
Speech recognition in noise in patients with type II diabetes
10.4103/indianjotol.indianjotol_101_19 · 2020 · External reference
Auditory temporal resolution in individuals with diabetes mellitus type 2
10.1055/s-0035-1571207 · 2016 · External reference
Speech perception performance of subjects with type I diabetes mellitus in noise
10.1016/j.bjorl.2016.07.003 · 2017 · External reference
Auditory late latency response in individuals with type 2 diabetes mellitus
10.5152/iao.2018.3201 · 2018 · External reference
Auditory event related potentials in children with autism spectrum disorder
10.1016/j.ijporl.2021.110826 · 2021 · External reference
Associations between rapid auditory processing of speech sounds and specific verbal communication skills in autism
10.3389/fpsyg.2023.1223250 · 2023 · External reference
Cognitive deficits in adolescents who developed diabetes early in life
10.1542/peds.75.5.921 · 1985 · External reference
Hypoglycemia induced by insulin as a triggering factor of cognitive deficit in diabetic children
2014 · External reference
Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus
10.1007/bf00405006 · 1991 · External reference
Visual information processing during controlled hypoglycaemia in humans
10.1093/brain/119.4.1277 · 1996 · External reference
Glucose availability and the electrophysiology of the human visual system
1997 · External reference
Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes
10.2337/diacare.27.10.2335 · 2004 · External reference
Higher fasting plasma glucose levels, within the normal range, are associated with decreased processing speed in high functioning young elderly
10.3233/jad-150433 · 2016 · External reference
Acute hypoglycemia in humans causes attentional dysfunction while nonverbal intelligence is preserved
10.2337/diacare.24.10.1745 · 2001 · External reference
Adaptation of cognitive function to hypoglycemia in healthy men
10.2337/diacare.23.8.1059 · 2000 · External reference
Peripheral insulin resistance attenuates cerebral glucose metabolism and impairs working memory in healthy adults
10.1038/s44324-024-00019-0 · 2024 · External reference
Impaired glucose regulation is associated with poorer performance on the stroop task
10.1016/j.physbeh.2013.09.001 · 2013 · External reference
Glucose regulation is associated with attentional control performances in nondiabetic older adults
10.1080/13803395.2011.589372 · 2011 · External reference
Differential impact of glycemic control and comorbid conditions on the neurophysiology underlying task switching in older adults with type 2 diabetes
10.18632/aging.204129 · 2022 · External reference
Acute hypoglycemia impairs executive cognitive function in adults with and without type 1 diabetes
10.2337/dc13-0194 · 2013 · External reference
Neurometabolic predictors of mental effort in the frontal cortex
10.1038/s41398-025-03554-6 · 2025 · External reference
The effect of acute hypoglycemia on brain function and activation: a functional magnetic resonance imaging study
10.2337/diabetes.50.7.1618 · 2001 · External reference
L-serine influences epigenetic modifications to improve cognition and behaviors in growth hormone-releasing hormone knockout mice
10.3390/biomedicines11010104 · 2022 · External reference
Function and therapeutic value of astrocytes in diabetic cognitive impairment
10.1016/j.neuint.2023.105591 · 2023 · External reference
Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains
10.1016/j.biopha.2022.114206 · 2023 · External reference
Bridging metabolic syndrome and cognitive dysfunction: role of astrocytes
2024 · External reference
Prevalence of epilepsy in autism spectrum disorders: a systematic review and meta-analysis
10.1177/13623613211045029 · 2022 · External reference
EEG features in autism spectrum disorder: a retrospective analysis in a cohort of preschool children
10.3390/brainsci13020345 · 2023 · External reference
Electroencephalographic abnormalities in autism spectrum disorder: characteristics and therapeutic implications
10.3390/medicina56090419 · 2020 · External reference
Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study
10.1007/s00125-016-4142-x · 2017 · External reference
Exploring the clinical connections between epilepsy and diabetes mellitus: promising therapeutic strategies utilizing agmatine and metformin
10.1007/s00210-024-03295-1 · 2024 · External reference
Glycaemic imbalances in seizures and epilepsy of paediatric age: a literature review
10.3390/jcm12072580 · 2023 · External reference
Astrocyte-neuron circuits in epilepsy
10.1016/j.nbd.2023.106058 · 2023 · External reference
Epilepsy and astrocyte energy metabolism
10.1002/glia.23247 · 2018 · External reference
Recent progress in the development of new antiepileptic drugs with novel targets
10.1177/09727531231185991 · 2023 · External reference
2-deoxyglucose and beta-hydroxybutyrate: metabolic agents for seizure control
10.3389/fncel.2019.00172 · 2019 · External reference
Hypoglycemic seizures during transient hypoglycemia exacerbate hippocampal dysfunction
10.1016/j.nbd.2007.03.002 · 2007 · External reference
Potential new roles for glycogen in epilepsy
10.1111/epi.17412 · 2023 · External reference
New insights on the potential anti-epileptic effect of metformin: mechanistic pathway
10.1111/jcmm.17965 · 2023 · External reference
Association between use of sodium–glucose cotransporter 2 inhibitors and epilepsy: a population-based study using target trial emulation
2025 · External reference
Dapagliflozin alleviated seizures and cognition impairment in pilocarpine induced status epilepticus via suppressing microglia-mediated neuroinflammation and oxidative stress
10.1016/j.intimp.2025.114117 · 2025 · External reference
Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy
10.1186/s12883-018-1086-4 · 2018 · External reference
Neurodevelopmental disorders, glycemic control, and diabetic complications in type 1 diabetes: a nationwide cohort study
10.1210/clinem/dgab467 · 2021 · External reference
Impaired intellectual development in children with type I diabetes: association with HbA(1c), age at diagnosis and sex
10.1007/s125-002-8250-6 · 2002 · External reference
Impact of dysglycemia and obesity on the brain in adolescents with and without type 2 diabetes: a pilot study
10.1111/pedi.13420 · 2022 · External reference
Cognitive function following diabetic ketoacidosis in children with new-onset or previously diagnosed type 1 diabetes
10.2337/dc20-0187 · 2020 · External reference
Screening for intellectual disability in autistic people: a brief report
10.1016/j.rasd.2022.102076 · 2023 · External reference
Astrocyte glycogen and lactate: new insights into learning and memory mechanisms
10.1002/glia.23250 · 2018 · External reference
Lack of neuronal glycogen impairs memory formation and learning-dependent synaptic plasticity in mice
10.3389/fncel.2019.00374 · 2019 · External reference
Inhibiting glycolysis rescues memory impairment in an intellectual disability Gdi1-null mouse
10.1016/j.metabol.2020.154463 · 2021 · External reference
Metabolic reprogramming in astrocytes results in neuronal dysfunction in intellectual disability
10.1038/s41380-022-01521-x · 2024 · External reference
Gastrointestinal disorders in diabetes
2024 · External reference
Gastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and management
10.2337/dc17-1536 · 2018 · External reference
Disorders of gastrointestinal motility associated with diabetes mellitus
10.7326/0003-4819-98-3-378 · 1983 · External reference
The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: a systematic review and meta-analysis
10.18632/aging.203854 · 2022 · External reference
Type II diabetes mellitus increases the risk of inflammatory bowel disease in a prospective cohort study
10.1016/j.clnesp.2024.03.022 · 2024 · External reference
Inflammatory bowel disease is more common in type 1 diabetes mellitus
10.1136/gut.2011.239301.438 · 2011 · External reference
Gastrointestinal issues and autism spectrum disorder
10.1016/j.chc.2020.02.005 · 2020 · External reference
Hydrogen breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in autism
10.1007/s00787-017-1039-2 · 2018 · External reference
Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases
2022 · External reference
Glucosensing in the gastrointestinal tract: impact on glucose metabolism
10.1152/ajpgi.00015.2016 · 2016 · External reference
Frequency of sleep disorders among patients with type 2 diabetes and contributing factors
2024 · External reference
The relationship between autism spectrum disorder and sleep
2021 · External reference
Analysis of sleep problem in children aged 1–3 years with autism spectrum disorder in Zhejiang Province, China
10.3389/fpsyt.2022.923757 · 2022 · External reference
Investigating differences in symptomatology and age at diagnosis of obstructive sleep apnea in children with and without autism
10.1016/j.ijporl.2022.111191 · 2022 · External reference
Association of sleep quality with insulin resistance in obese or overweight subjects
10.5935/1984-0063.20200084 · 2021 · External reference
The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise
10.3389/fphys.2011.00112 · 2011 · External reference
Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes
10.2337/diabetes.49.2.263 · 2000 · External reference
Impaired glycogen synthase activity and mitochondrial dysfunction in skeletal muscle: markers or mediators of insulin resistance in type 2 diabetes?
10.2174/1573399810602040375 · 2006 · External reference
The influence of circadian rhythms and aerobic glycolysis in autism spectrum disorder
10.1038/s41398-020-01086-9 · 2020 · External reference
Nocturnal hypoglycemia associated with bizarre nighttime behavior
10.1378/chest.124.4_meetingabstracts.306s · 2003 · External reference
Abnormal nocturnal behavior due to hypoglycemia: a case report
10.1097/md.0000000000014405 · 2019 · External reference
Acute hyperglycemia associated with psychotic symptoms in a patient with type 1 diabetes mellitus: a case report
2016 · External reference
Common mechanisms for type 2 diabetes and psychosis: findings from a prospective birth cohort
10.1016/j.schres.2020.08.006 · 2020 · External reference
Delirium and psychotic symptoms associated with hyperglycemia in a patient with poorly controlled type 2 diabetes mellitus
2018 · External reference
Psychosis associated with hyperglycemia in a female patient with type 1 diabetes mellitus: a case report
2024 · External reference
MON-684 Neuroglycopenia: avoiding bias in patients with acute psychosis
2020 · External reference
Hypoglycemia masquerading as acute psychosis in young age
10.1186/cc892 · 2000 · External reference
Psychosis in adults with autism spectrum disorder and attention deficit hyperactivity disorder at acute psychiatric wards
10.1016/j.ejpsy.2022.12.001 · 2023 · External reference
Recognizing psychosis in autism spectrum disorder
10.3389/fpsyt.2022.768586 · 2022 · External reference
Psychosis in a child with atypical autism: a case report and a brief review of the association of psychosis and autism
2018 · External reference
Recognition of psychosis in persons who do not use spoken communication
1994 · External reference
Rett syndrome: a neurological disorder with metabolic components
10.1098/rsob.170216 · 2018 · External reference
Systemic proteome phenotypes reveal defective metabolic flexibility in Mecp2 mutants
10.1093/hmg/ddad154 · 2023 · External reference
The anti-diabetic drug metformin rescues aberrant mitochondrial activity and restrains oxidative stress in a female mouse model of Rett syndrome
10.3390/jcm9061669 · 2020 · External reference
Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome
10.1016/j.neuropharm.2022.109350 · 2023 · External reference
Chromosomal deletions on 16p11.2 encompassing SH2B1 are associated with accelerated metabolic disease
2023 · External reference
16p11.2 haploinsufficiency reduces mitochondrial biogenesis in brain endothelial cells and alters brain metabolism in adult mice
10.1016/j.celrep.2023.112485 · 2023 · External reference
A hypothesis: metabolic contributions to 16p11.2 deletion syndrome
10.1002/bies.202400177 · 2025 · External reference
Examining the overlap between autism spectrum disorder and 22q11.2 deletion syndrome
10.3390/ijms18051071 · 2017 · External reference
22q11.2 microdeletion and increased risk for type 2 diabetes
10.1016/j.eclinm.2020.100528 · 2020 · External reference
Obesity and metabolic syndrome in adults with a 22q11.2 microdeletion
10.1038/s41366-024-01685-2 · 2025 · External reference
Mitochondrial citrate transporter-dependent metabolic signature in the 22q11.2 deletion syndrome
10.1074/jbc.m115.672360 · 2015 · External reference
Disruption of the blood–brain barrier in 22q11.2 deletion syndrome
10.1093/brain/awab055 · 2021 · External reference
Role of astrocyte dysfunctions in 22q11 deletion syndrome
10.1016/j.biopsych.2020.02.307 · 2020 · External reference
Association of mitochondrial biogenesis with variable penetrance of schizophrenia
10.1001/jamapsychiatry.2021.0762 · 2021 · External reference
Calcium channels in postnatal development of rat pancreatic beta cells and their role in insulin secretion
10.3389/fendo.2018.00040 · 2018 · External reference
Multiple beta cell-independent mechanisms drive hypoglycemia in Timothy syndrome
10.1038/s41467-024-52885-3 · 2024 · External reference
Intracellular calcium leak lowers glucose storage in human muscle, promoting hyperglycemia and diabetes
10.7554/elife.53999 · 2020 · External reference
The distinct roles of calcium in rapid control of neuronal glycolysis and the tricarboxylic acid cycle
10.7554/elife.64821 · 2021 · External reference
Ca2+ as the prime trigger of aerobic glycolysis in astrocytes
10.1016/j.ceca.2021.102368 · 2021 · External reference
Calcium signaling at the interface between astrocytes and brain inflammation
10.1016/j.conb.2024.102940 · 2025 · External reference
Mitochondria and neuronal activity
10.1152/ajpcell.00222.2006 · 2007 · External reference
Neuronal calcium homeostasis and dysregulation
10.1089/ars.2010.3386 · 2011 · External reference
The roles of mitochondria in global and local intracellular calcium signalling
10.1038/s41580-024-00820-1 · 2025 · External reference
Regulation and metabolic functions of mTORC1 and mTORC2
10.1152/physrev.00026.2020 · 2021 · External reference
mTORC1 activation drives astrocyte reactivity in cortical tubers and brain organoid models of TSC
2025 · External reference
Selective disruption of mTORC1 and mTORC2 in VTA astrocytes induces depression and anxiety-like behaviors in mice
10.1016/j.bbr.2024.114888 · 2024 · External reference
Neuronal mTORC1 is required for maintaining the nonreactive state of astrocytes
10.1074/jbc.m116.744482 · 2017 · External reference
Physiological and pathological role of mTOR signaling in astrocytes
10.1007/s11064-024-04306-6 · 2024 · External reference
The metformin in tuberous sclerosis (MiTS) study: a randomised double-blind placebo-controlled trial
10.1016/j.eclinm.2020.100715 · 2021 · External reference
The fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice
10.1093/hmg/ddu737 · 2015 · External reference
The translational regulator FMRP controls lipid and glucose metabolism in mice and humans
10.1016/j.molmet.2019.01.002 · 2019 · External reference
A metabolomic and systems biology perspective on the brain of the fragile X syndrome mouse model
10.1101/gr.116764.110 · 2011 · External reference
BCKDK deficiency: a treatable neurodevelopmental disease amenable to newborn screening
10.1093/brain/awad010 · 2023 · External reference
Mitochondrial response to the BCKDK-deficiency: some clues to understand the positive dietary response in this form of autism
10.1016/j.bbadis.2016.01.016 · 2016 · External reference
BCKDK regulates the TCA cycle through PDC in the absence of PDK family during embryonic development
10.1016/j.devcel.2021.03.007 · 2021 · External reference
BCAA catabolic defect alters glucose metabolism in lean mice
10.3389/fphys.2019.01140 · 2019 · External reference
Partial suppression of BCAA catabolism as a potential therapy for BCKDK deficiency
2024 · External reference
Genetic and epigenetic regulation of Treg cell fitness by autism-related chromatin remodeler CHD8
10.1186/s11658-025-00711-z · 2025 · External reference
Autism-associated CHD8 controls reactive gliosis and neuroinflammation via remodeling chromatin in astrocytes
10.1016/j.celrep.2024.114637 · 2024 · External reference
Metabolomic profiling of the striatum in Shank3 knockout ASD rats: effects of early swimming regulation
10.3390/metabo15020134 · 2025 · External reference
Altered neurogenesis and disrupted expression of synaptic proteins in prefrontal cortex of SHANK3-deficient non-human primate
10.1038/cr.2017.95 · 2017 · External reference
CRISPR/Cas9-mediated disruption of SHANK3 in monkey leads to drug-treatable autism-like symptoms
10.1093/hmg/ddy367 · 2019 · External reference
Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases
10.1002/med.21867 · 2022 · External reference
Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes
10.1007/s00213-011-2190-y · 2011 · External reference
Involvement of myocyte enhancer factor 2c in the pathogenesis of autism spectrum disorder
10.1016/j.heliyon.2021.e06854 · 2021 · External reference
Myocyte enhancer factor 2C function in skeletal muscle is required for normal growth and glucose metabolism in mice
10.1186/s13395-015-0031-0 · 2015 · External reference
Loss of MEF2C function by enhancer mutation leads to neuronal mitochondria dysfunction and motor deficits in mice
10.1186/s13024-024-00792-y · 2025 · External reference
Autism spectrum disorder risk genes have convergent effects on transcription and neuronal firing patterns in primary neurons
2025 · External reference
Autism-like behaviors and abnormality of glucose metabolism in offspring derived from aging males with epigenetically modified sperm
10.18632/aging.104061 · 2020 · External reference
Dnmt3a is an epigenetic mediator of adipose insulin resistance
10.7554/elife.30766 · 2017 · External reference
Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
2023 · External reference
SETD5 haploinsufficiency affects mitochondrial compartment in neural cells
10.1186/s13229-023-00550-9 · 2023 · External reference
The essential role of Mbd5 in the regulation of somatic growth and glucose homeostasis in mice
10.1371/journal.pone.0047358 · 2012 · External reference
The methyltransferase enzymes KMT2D, SETD1B, and ASH1L are key mediators of both metabolic and epigenetic changes during cellular senescence
10.1091/mbc.e20-08-0523 · 2022 · External reference
Disrupted prenatal metabolism may explain the etiology of suboptimal neurodevelopment: a focus on phthalates and micronutrients and their relationship to autism spectrum disorder
10.1016/j.advnut.2024.100279 · 2024 · External reference
Autism spectrum disorder and particulate matter air pollution before, during, and after pregnancy: a nested case–control analysis within the nurses' health Study II cohort
10.1289/ehp.1408133 · 2015 · External reference
Exploring the association between early-life air pollution exposure and autism spectrum disorders in children: a systematic review and meta-analysis
10.1016/j.reprotox.2024.108582 · 2024 · External reference
Environmental pollutants as risk factors for autism spectrum disorders: a systematic review and meta-analysis of cohort studies
10.1186/s12889-024-19742-w · 2024 · External reference
Exposure to inorganic arsenic and lead and autism spectrum disorder in children: a systematic review and meta-analysis
10.1021/acs.chemrestox.9b00134 · 2019 · External reference
Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence
2014 · External reference
Association between heavy metals exposure (cadmium, lead, arsenic, mercury) and child autistic disorder: a systematic review and meta-analysis
10.3389/fped.2023.1169733 · 2023 · External reference
Exposure to heavy metals in utero and autism spectrum disorder at age 3: a meta-analysis of two longitudinal cohorts of siblings of children with autism
10.1186/s12940-024-01101-2 · 2024 · External reference
Arsenic exposure via drinking water during pregnancy and lactation induces autism-like behaviors in male offspring mice
10.1016/j.chemosphere.2021.133338 · 2022 · External reference
Autism-like behavior and epigenetic changes associated with autism as consequences of in utero exposure to environmental pollutants in a mouse model
2015 · External reference
Associations of prenatal metal exposure with child neurodevelopment and mediation by perturbation of metabolic pathways
10.1038/s41467-025-57253-3 · 2025 · External reference
Editorial: the outcomes of pollutants on glia
10.3389/fncel.2024.1444344 · 2024 · External reference
Impacts of ambient air pollution on glucose metabolism in Korean adults: a Korea national health and nutrition examination survey study
10.1186/s12940-020-00623-9 · 2020 · External reference
Longitudinal associations between ambient air pollution with insulin sensitivity, β-cell function, and adiposity in Los Angeles Latino children
10.2337/db16-1416 · 2017 · External reference
Air pollution and diabetes-related biomarkers in non-diabetic adults: a pathway to impaired glucose metabolism?
10.1016/j.envint.2019.01.005 · 2019 · External reference
Glial smog: interplay between air pollution and astrocyte-microglia interactions
10.1016/j.neuint.2020.104715 · 2020 · External reference
Neurotoxicity and the global worst pollutants: astroglial involvement in arsenic, lead, and mercury intoxication
10.1007/s11064-022-03725-7 · 2023 · External reference
Environmental toxicants in the brain: a review of astrocytic metabolic dysfunction
10.1016/j.etap.2021.103608 · 2021 · External reference
Structure–activity relationship of lower chlorinated biphenyls and their human-relevant metabolites for astrocyte toxicity
10.1021/acs.chemrestox.3c00095 · 2023 · External reference
Arsenite stimulates glutathione export and glycolytic flux in viable primary rat brain astrocytes
10.1016/j.neuint.2014.06.013 · 2014 · External reference
Advanced parental age and autism risk in children: a systematic review and meta-analysis
10.1111/acps.12666 · 2017 · External reference
Association of grandparental and parental age at childbirth with autism spectrum disorder in children
10.1001/jamanetworkopen.2020.2868 · 2020 · External reference
Advancing maternal age is associated with increasing risk for autism: a review and meta-analysis
10.1016/j.jaac.2012.02.018 · 2012 · External reference
Advanced paternal age increased metabolic risks in mice offspring
10.1016/j.bbadis.2022.166355 · 2022 · External reference
Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders
10.1542/peds.2011-2583 · 2012 · External reference
Prenatal and perinatal metabolic risk factors for autism: a review and integration of findings from population-based studies
10.1097/yco.0000000000000673 · 2021 · External reference
Advanced maternal age-related clustering of metabolic abnormalities is associated with risks of adverse pregnancy outcomes
10.1016/j.jfma.2023.11.013 · 2024 · External reference
Maternal obesity and diabetes are linked to children's autism and similar disorders
10.1136/bmj.e2768 · 2012 · External reference
Prenatal glucose intolerance and child neurodevelopmental disorders
10.1001/jamanetworkopen.2025.41657 · 2025 · External reference
A western dietary pattern during pregnancy is associated with neurodevelopmental disorders in childhood and adolescence
10.1038/s42255-025-01230-z · 2025 · External reference
Pioglitazone reversed the fructose-programmed astrocytic glycolysis and oxidative phosphorylation of female rat offspring
10.1152/ajpendo.00408.2018 · 2019 · External reference
Effect of maternal diabetes on the expression of genes regulating fetal brain glucose uptake
10.2337/diab.42.10.1487 · 1993 · External reference
Maternal Western diet programs cardiometabolic dysfunction and hypothalamic inflammation via epigenetic mechanisms predominantly in the male offspring
10.1016/j.molmet.2023.101864 · 2024 · External reference
Maternal obesity/diabetes, plasma branched-chain amino acids, and autism spectrum disorder risk in urban low-income children: evidence of sex difference
10.1002/aur.2177 · 2019 · External reference
Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism
10.1001/jama.2013.2270 · 2013 · External reference
A narrative review on the effect of valproic acid on the placenta
10.1002/bdr2.2471 · 2025 · External reference
Neonatal episodic hypoglycemia: a finding of valproic acid withdrawal
10.4274/jcrpe.v2i2.92 · 2010 · External reference
Glycolysis mediates neuron specific histone acetylation in valproic acid-induced human excitatory neuron differentiation
10.3389/fnmol.2023.1151162 · 2023 · External reference
Amelioration of biased neuronal differentiation in humanized mouse model of valproic acid-induced autism by precisely targeted transcranial magnetic stimulation
10.1002/btm2.10748 · 2025 · External reference
Maternal infection during pregnancy and autism spectrum disorders
10.1007/s10803-013-2016-3 · 2015 · External reference
Differential transmission and postnatal outcomes in triplets with intrauterine cytomegalovirus infection
10.2350/11-05-1034-cr.1 · 2012 · External reference
Autism spectrum disorder diagnoses and congenital cytomegalovirus
10.1542/peds.2023-064081 · 2024 · External reference
Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome
10.1016/j.bbadis.2024.167097 · 2024 · External reference
Rubella virus infection, the congenital rubella syndrome, and the link to autism
10.3390/ijerph16193543 · 2019 · External reference
Modeling autism-related disorders in mice with maternal immune activation (MIA)
2019 · External reference
Postnatal cytomegalovirus infection may increase the susceptibility of Tuberous sclerosis complex to autism spectrum disorders
2022 · External reference
Immune activation during pregnancy exacerbates ASD-related alterations in Shank3-deficient mice
10.1186/s13229-022-00532-3 · 2023 · External reference
Lipopolysaccharide induces neuroinflammation in a valproic acid male model of autism
10.1016/j.brainresbull.2024.111154 · 2025 · External reference
Establishment of a two-hit mouse model of environmental factor induced autism spectrum disorder
2024 · External reference
Stealing the keys to the kitchen: viral manipulation of the host cell metabolic network
10.1016/j.tim.2015.08.007 · 2015 · External reference
How viral and intracellular bacterial pathogens reprogram the metabolism of host cells to allow their intracellular replication
10.3389/fcimb.2019.00042 · 2019 · External reference
Early effects of LPS-induced neuroinflammation on the rat hippocampal glycolytic pathway
10.1186/s12974-022-02612-w · 2022 · External reference
Human herpesvirus 6A promotes glycolysis in infected T cells by activation of mTOR signaling
10.1371/journal.ppat.1008568 · 2020 · External reference
Rubella viruses shift cellular bioenergetics to a more oxidative and glycolytic phenotype with a strain-specific requirement for glutamine
10.1128/jvi.00934-18 · 2018 · External reference
Role of immunometabolism during congenital cytomegalovirus infection
10.1097/in9.0000000000000034 · 2023 · External reference
Human cytomegalovirus induces the expression of the AMPKa2 subunit to drive glycolytic activation and support productive viral infection
10.1128/jvi.01321-20 · 2021 · External reference
Contribution of carbohydrate-related metabolism in herpesvirus infections
2023 · External reference
Glucose-independent human cytomegalovirus replication is supported by metabolites that feed upper glycolytic branches
10.1073/pnas.2412966121 · 2024 · External reference
Divergent effects of human cytomegalovirus and herpes simplex Virus-1 on cellular metabolism
10.1371/journal.ppat.1002124 · 2011 · External reference
Maternal-fetal cross-talk via the placenta: influence on offspring development and metabolism
10.1242/dev.202088 · 2023 · External reference
Developing brain under renewed attack: viral infection during pregnancy
10.3389/fnins.2023.1119943 · 2023 · External reference
Astrocytes are a key target for neurotropic viral infection
10.3390/cells12182307 · 2023 · External reference
Selective infection of astrocytes in human glial cell cultures by rubella virus
1995 · External reference
Human cytomegalovirus replication and modulation of apoptosis in astrocytes
1999 · External reference
Bystander attenuation of neuronal and astrocyte intercellular communication by murine cytomegalovirus infection of glia
10.1128/jvi.02501-06 · 2007 · External reference
Astrocytes lingering at a crossroads: neuroprotection and neurodegeneration in neurocognitive dysfunction
10.7150/ijbs.109315 · 2025 · External reference
SARS-CoV2 infection triggers inflammatory conditions and astrogliosis-related gene expression in long-term human cortical organoids
10.1093/stmcls/sxaf010 · 2025 · External reference
Breaking the barrier: the role of proinflammatory cytokines in BBB dysfunction
10.3390/ijms26083532 · 2025 · External reference
Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications
10.1080/13550280152058799 · 2001 · External reference
Astrogliopathology in the infectious insults of the brain
10.1016/j.neulet.2018.08.003 · 2019 · External reference
Astrocytes play a key role in activation of microglia by persistent Borna disease virus infection
10.1186/1742-2094-5-50 · 2008 · External reference
Human cytomegalovirus disruption of calcium signaling in neural progenitor cells and organoids
10.1128/jvi.00954-19 · 2019 · External reference
Tumor necrosis factor-alpha and interleukin-1 alpha enhance glucose utilization by astrocytes: involvement of phospholipase A2
10.1016/s0026-895x(25)10505-1 · 1995 · External reference
Differential effects of pro- and anti-inflammatory cytokines alone or in combinations on the metabolic profile of astrocytes
10.1111/j.1471-4159.2010.07135.x · 2011 · External reference
Acute inflammation alters brain energy metabolism in mice and humans: role in suppressed spontaneous activity, impaired cognition, and delirium
10.1523/jneurosci.2876-19.2020 · 2020 · External reference
Modulation of astrocytic metabolic phenotype by proinflammatory cytokines
10.1002/glia.20671 · 2008 · External reference
Postoperative cognitive dysfunction-current research progress
10.3389/fnbeh.2024.1328790 · 2024 · External reference
Impaired glucose utilization in the brain of patients with delirium following hip fracture
10.1093/brain/awad296 · 2024 · External reference
Protective effect of intranasal insulin on postoperative cognitive dysfunction in elderly patients with metabolic syndrome undergoing noncardiac surgery: a randomized clinical trial
10.1007/s40520-023-02593-7 · 2023 · External reference
Sickness behavior in animals: implications for health and wellness
2019 · External reference
The legacy of sickness behaviors
10.3389/fpsyt.2020.607269 · 2020 · External reference
Immunological mechanisms of sickness behavior in viral infection
10.3390/v13112245 · 2021 · External reference
The immunology of sickness metabolism
10.1038/s41423-024-01192-4 · 2024 · External reference
Twenty years of research on cytokine-induced sickness behavior
10.1016/j.bbi.2006.09.006 · 2007 · External reference
Reactive astrocyte nomenclature, definitions, and future directions
10.1038/s41593-020-00783-4 · 2021 · External reference
Astrocyte-mediated inflammatory responses in traumatic brain injury: mechanisms and potential interventions
2025 · External reference
Metabolic reprogramming in astrocytes distinguishes region-specific neuronal susceptibility in Huntington Mice
10.1016/j.cmet.2019.03.004 · 2019 · External reference
The high costs of low-grade inflammation: persistent fatigue as a consequence of reduced cellular-energy availability and non-adaptive energy expenditure
10.3389/fnbeh.2018.00078 · 2018 · External reference
Inflammation-induced mitochondrial and metabolic disturbances in sensory neurons control the switch from acute to chronic pain
2023 · External reference
Hyperglycemia enhances brain susceptibility to lipopolysaccharide-induced neuroinflammation via astrocyte reprogramming
10.1186/s12974-024-03136-1 · 2024 · External reference
Infection and immunometabolism in the central nervous system: a possible mechanistic link between metabolic imbalance and dementia
10.3389/fncel.2021.765217 · 2021 · External reference
Sociality and sickness: have cytokines evolved to serve social functions beyond times of pathogen exposure?
10.1016/j.bbi.2013.10.021 · 2014 · External reference
Autism spectrum disorder and a possible role of anti-inflammatory treatments: experience in the pediatric allergy/immunology clinic
10.3389/fpsyt.2024.1333717 · 2024 · External reference
Trained immunity: adaptation within innate immune mechanisms
10.1152/physrev.00031.2021 · 2023 · External reference
Social functioning and autistic behaviors in youth following acquired brain injury
10.3390/children9111648 · 2022 · External reference
Autism spectrum disorder in children with an early history of paediatric acquired brain injury
10.3390/jcm12134361 · 2023 · External reference
Traumatic brain injury in early childhood and risk of attention-deficit/hyperactivity disorder and autism spectrum disorder: a nationwide longitudinal study
10.4088/jcp.17m11857 · 2018 · External reference
Metabolic response of pediatric traumatic brain injury
10.1177/0883073814549244 · 2016 · External reference
Glucose metabolism following human traumatic brain injury: methods of assessment and pathophysiological findings
10.1007/s11011-014-9628-y · 2015 · External reference
Therapeutic effect of intensive glycemic control therapy in patients with traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials
2018 · External reference
Brain injury biomarkers as targets for drugs development and personalized treatment for traumatic brain injury patients
10.3389/fphar.2025.1606174 · 2025 · External reference
A nationwide study in Denmark of the association between treated infections and the subsequent risk of treated mental disorders in children and adolescents
10.1001/jamapsychiatry.2018.3428 · 2019 · External reference
Pediatric autoimmune encephalitis
10.4103/jpn.jpn_185_16 · 2017 · External reference
Autoimmune encephalitis and autism spectrum disorder
10.3389/fpsyt.2021.775017 · 2021 · External reference
Risk of psychiatric neurodevelopmental disorders after meningitis in childhood: a nationwide, population-based cohort study
10.1080/23744235.2024.2399101 · 2025 · External reference
Autism following a history of newborn encephalopathy: more than a coincidence?
10.1017/s001216220600020x · 2006 · External reference
Viral encephalitis and neurologic diseases: focus on astrocytes
10.1016/j.molmed.2018.09.001 · 2018 · External reference
Lactate and glucose concentrations in brain interstitial fluid, cerebrospinal fluid, and serum during experimental pneumococcal meningitis
10.1093/infdis/166.3.546 · 1992 · External reference
Morphological, cellular, and molecular basis of brain infection in COVID-19 patients
10.1073/pnas.2200960119 · 2022 · External reference
Onset at age 14 of a typical autistic syndrome. A case report of a girl with herpes simplex encephalitis
10.1007/bf01531665 · 1986 · External reference
Autistic symptoms following herpes encephalitis
10.1007/s00787-002-0271-5 · 2002 · External reference
Autistic syndrome with onset at age 31 years: herpes encephalitis as a possible model for childhood autism
10.1111/j.1469-8749.1991.tb14804.x · 1991 · External reference
Etiologies of autism in a case-series from Tanzania
10.1007/s10803-006-0143-9 · 2006 · External reference
Risk of neuropsychiatric and related conditions associated with SARS-CoV-2 infection: a difference-in-differences analysis
10.1038/s41467-025-61961-1 · 2025 · External reference
Neurodevelopmental outcomes of 3-year-old children exposed to maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in utero
10.1097/aog.0000000000006112 · 2026 · External reference
COVID-19 autism spectrum disorder-like transient neurocognitive clinical presentation
10.1136/bcr-2024-259782 · 2024 · External reference
The development of a Q-sort behavioral rating procedure for pediatric HIV patients
10.1093/jpepsy/19.1.27 · 1994 · External reference
Primary neurological manifestations of HIV in children
10.3855/jidc.17645 · 2023 · External reference
Impairment of expressive behavior in pediatric HIV-infected patients with evidence of CNS disease
10.1093/jpepsy/21.3.379 · 1996 · External reference
Regression of attained milestones in an HIV infected Infant
10.1007/bf02722605 · 2001 · External reference
Adaptive behavior of children with symptomatic HIV infection before and after zidovudine therapy
10.1093/jpepsy/19.1.47 · 1994 · External reference
Neurodevelopmental/neuroradiologic recovery of a child infected with HIV after treatment with combination antiretroviral therapy using the HIV-specific protease inhibitor ritonavir
10.1542/peds.101.3.e7 · 1998 · External reference
Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children
10.1542/peds.2004-1108 · 2005 · External reference
HIV-1 infection alters energy metabolism in the brain: contributions to HIV-associated neurocognitive disorders
10.1016/j.pneurobio.2019.101616 · 2019 · External reference
Metabolic syndrome and neurocognitive deficits in HIV infection
10.1097/qai.0000000000001964 · 2019 · External reference
Insulin treatment prevents neuroinflammation and neuronal injury with restored neurobehavioral function in models of HIV/AIDS neurodegeneration
10.1523/jneurosci.1287-16.2016 · 2016 · External reference
Bioenergetic adaptations to HIV infection. Could modulation of energy substrate utilization improve brain health in people living with HIV-1?
10.1016/j.expneurol.2020.113181 · 2020 · External reference
Children with perinatal stroke are at increased risk for autism spectrum disorder: prevalence and co-occurring conditions within a clinically followed sample
10.1080/13854046.2021.1955150 · 2022 · External reference
Risk of autism after pediatric ischemic stroke: a nationwide cohort study
10.1212/wnl.0000000000200253 · 2022 · External reference
The specific role of reactive astrocytes in stroke
2022 · External reference
Investigation of long-term metabolic alteration after stroke in tMCAO (transient middle cerebral artery occlusion) mouse model using metabolomics approach
10.1016/j.neulet.2022.136492 · 2022 · External reference
Designing innovative interventions for metabolic neuropsychiatry
2025 · External reference
Glucose-sparing action of ketones boosts functions exclusive to glucose in the brain
10.1523/eneuro.0303-20.2020 · 2020 · External reference
A ketogenic diet and the treatment of autism spectrum disorder
2021 · External reference
Therapeutic use of carbohydrate-restricted diets in an autistic child; a case report of clinical and 18FDG PET findings
10.1007/s11011-018-0219-1 · 2018 · External reference
A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder
10.1016/j.physbeh.2018.02.006 · 2018 · External reference
Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder
10.1371/journal.pone.0171643 · 2017 · External reference
Supplementation of regular diet with medium-chain triglycerides for procognitive effects: a narrative review
10.3389/fnut.2022.934497 · 2022 · External reference
Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia
10.2337/db08-1557 · 2009 · External reference
Astrocyte metabolism of the medium-chain fatty acids octanoic acid and decanoic acid promotes GABA synthesis in neurons via elevated glutamine supply
10.1186/s13041-021-00842-2 · 2021 · External reference
Cerebral metabolic effects of exogenous lactate supplementation on the injured human brain
10.1007/s00134-013-3203-6 · 2014 · External reference
Lactate metabolism, signaling, and function in brain development, synaptic plasticity, angiogenesis, and neurodegenerative diseases
2023 · External reference
Current knowledge about pyruvate supplementation: a brief review
10.1016/j.smhs.2024.02.007 · 2024 · External reference
Effects of pyruvate administration on mitochondrial enzymes, neurological behaviors, and neurodegeneration after traumatic brain injury
10.14336/ad.2020.1015 · 2021 · External reference
Role of pyruvate in maintaining cell viability and energy production under high-glucose conditions
10.1038/s41598-021-98082-w · 2021 · External reference
Chronic pyruvate supplementation increases exploratory activity and brain energy reserves in young and middle-aged mice
10.3389/fnagi.2016.00041 · 2016 · External reference
Metabolic correction by pyruvate halts acquired epilepsy in multiple rodent models
10.1016/j.nbd.2017.07.012 · 2017 · External reference
Impairments in oxidative glucose metabolism in epilepsy and metabolic treatments thereof
10.3389/fncel.2018.00274 · 2018 · External reference
Creatine monohydrate pilot in Alzheimer's: feasibility, brain creatine, and cognition
2025 · External reference
“Heads up” for creatine supplementation and its potential applications for brain health and function
10.1007/s40279-023-01870-9 · 2023 · External reference
Potential role of creatine as an anticonvulsant agent: evidence from preclinical studies
10.3389/fnins.2023.1201971 · 2023 · External reference
Potential of creatine in glucose management and diabetes
10.3390/nu13020570 · 2021 · External reference
Creatine deficiency syndromes
10.1016/b978-0-444-59565-2.00053-8 · 2013 · External reference
Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American college of medical genetics and genomics
10.1038/gim.2016.203 · 2017 · External reference
Generation of ketone bodies from leucine by cultured astroglial cells
10.1046/j.1471-4159.1995.65062450.x · 1995 · External reference
Metabolic and regulatory roles of leucine in neural cells
10.1007/s11064-007-9444-4 · 2008 · External reference
Potent anti-seizure effects of D-leucine
10.1016/j.nbd.2015.05.013 · 2015 · External reference
Muscle-building supplement β-hydroxy β-methylbutyrate binds to PPARα to improve hippocampal functions in mice
10.1016/j.celrep.2023.112717 · 2023 · External reference
Suppression of experimental autoimmune encephalomyelitis in mice by β-hydroxy β-methylbutyrate, a body-building supplement in humans
10.4049/jimmunol.2200267 · 2023 · External reference
Effects of β-hydroxy β-methylbutyrate supplementation on working memory and hippocampal long-term potentiation in rodents
10.3390/nu14051090 · 2022 · External reference
Metabolic and functional effects of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in skeletal muscle
10.1007/s00421-011-2224-5 · 2012 · External reference
l-serine links metabolism with neurotransmission
10.1016/j.pneurobio.2020.101896 · 2021 · External reference
L-serine: a neglected amino acid with a potential therapeutic role in diabetes
10.1111/apm.12987 · 2019 · External reference
A clinical study of urine amino acids in children with autism spectrum disorder
10.3390/life14050629 · 2024 · External reference
Population pharmacokinetic and pharmacodynamic model guided weight-tiered dose of AST-001 in pediatric patients with autism spectrum disorder
10.3389/fphar.2024.1452526 · 2024 · External reference
Folic acid deficiency increases sensitivity to DNA damage by glucose and methylglyoxal
10.1093/mutage/geac003 · 2022 · External reference
Sugar as a therapeutic target for the cognitive restoration following traumatic brain injury
10.1097/wco.0000000000000752 · 2019 · External reference
High-dose leucovorin reverses acute high-dose methotrexate neurotoxicity in the rat
10.1002/ana.410250408 · 1989 · External reference
Effects of folic acid supplementation in pregnant mice on glucose metabolism disorders in male offspring induced by lipopolysaccharide exposure during pregnancy
10.1038/s41598-023-31690-w · 2023 · External reference
Central effects of acute intranasal insulin on neuroimaging, cognitive, and behavioural outcomes: a systematic review
10.1016/j.neubiorev.2024.105907 · 2024 · External reference
Hot spots for the use of intranasal insulin: cerebral ischemia, brain injury, diabetes mellitus, endocrine disorders and postoperative delirium
10.3390/ijms24043278 · 2023 · External reference
Alzheimer's disease as a form of in situ diabetes: a systematic review and meta-analysis of therapeutic approaches using intranasal insulin treatment
2024 · External reference
Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans
10.2337/db12-0025 · 2012 · External reference
Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin
10.1002/jnr.21787 · 2008 · External reference
Intranasal insulin alleviates traumatic brain injury by inhibiting autophagy and endoplasmic reticulum stress-mediated apoptosis through the PI3K/Akt/mTOR signaling pathway
10.1016/j.neuroscience.2023.08.009 · 2023 · External reference
Intranasal insulin eases autism in rats via GDF-15 and anti-inflammatory pathways
10.3390/cimb46090624 · 2024 · External reference
A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome
10.1186/2040-2392-5-54 · 2014 · External reference
Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial
10.1038/ejhg.2016.109 · 2016 · External reference
Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial
10.1177/02698811241303593 · 2025 · External reference
Metformin administration during early postnatal life rescues autistic-like behaviors in the BTBR T+ Itpr3tf/J mouse model of autism
10.3389/fnbeh.2018.00290 · 2018 · External reference
Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: mechanistic study of risperidone and metformin monotherapy versus combination
10.1016/j.pnpbp.2022.110522 · 2022 · External reference
Metformin treatment in young children with fragile X syndrome
2019 · External reference
Metformin as targeted treatment in fragile X syndrome
10.1111/cge.13039 · 2018 · External reference
Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin-two cases
2019 · External reference
Peroxisome proliferator-activated receptor γ thiazolidinedione agonists increase glucose metabolism in astrocytes
10.1074/jbc.m208132200 · 2003 · External reference
Microglia and astrocyte activation by toll-like receptor ligands: modulation by PPAR-γ agonists
10.1155/2008/453120 · 2008 · External reference
Insulin receptor sensitization restores neocortical excitation/inhibition balance in a mouse model of autism
10.1186/s13229-018-0196-6 · 2018 · External reference
Effect of pioglitazone treatment on behavioral symptoms in autistic children
10.1186/1742-2094-4-3 · 2007 · External reference
A pilot dose finding study of pioglitazone in autistic children
10.1186/s13229-018-0241-5 · 2018 · External reference
Repurposing SGLT2 inhibitors for neurological disorders: a focus on the autism spectrum disorder
10.3390/molecules27217174 · 2022 · External reference
Canagliflozin alleviates valproic acid-induced autism in rat pups: role of PTEN/PDK/PPAR-γ signaling pathways
10.3389/fphar.2023.1113966 · 2023 · External reference
